28. Michael S, Auld D, Klumpp C, Jadhav A, Zheng W, et al. (2008) A robotic platform for quantitative high-throughput screening. Assay Drug Dev Technol 6: 637–657. 29. Hill AV (1910) The possible effects of the aggregation of the molecule of haemoglobin on its dissociation curves. J Physiol(London). 4–7. 30. Roberts G, Myatt GJ, Johnson WP, Cross KP, Blower PE, Jr. (2000) LeadScope: software for exploring large sets of screening data. J Chem Inf Comput Sci 40: 1302–1314. 31. Wilson DM, 3rd, Takeshita M, Grollman AP, Demple B (1995) Incision activity of human apurinic endonuclease (Ape) at abasic site analogs in DNA. J Biol Chem 270: 16002–16007. 32. Wilson DM, 3rd (2005) Ape1 abasic endonuclease activity is regulated by magnesium and potassium concentrations and is robust on alternative DNA structures. J Mol Biol 345: 1003–1014. 33. Zhang JH, Chung TD, Oldenburg KR (1999) A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J Biomol Screen 4: 67–73. 34. Eastwood BJ, Farmen MW, Iversen PW, Craft TJ, Smallwood JK, et al. (2006) The Minimum Significant Ratio: A Statistical Parameter to Characterize the Reproducibility of Potency Estimates from Concentration-Response Assays and Estimation by Replicate-Experiment Studies. J Biomol Screen 11: 253–261. 35. Jadhav A, Ferreira R, Klumpp C, Mott BT, Austin C, et al. (2010) Quantitative Analyses of Aggregation, Autofluorescence, and Reactivity Artifacts in a Screen for Inhibitors of a Thiol Protease J Med Chem 53: 37–51. 36. Erzberger JP, Barsky D, Scharer OD, Colvin ME, Wilson DM, 3rd (1998) Elements in abasic site recognition by the major human and Escherichia coli apurinic/apyrimidinic endonucleases. Nucl Acids Res 26: 2771–2778. 37. Mol CD, Hosfield DJ, Tainer JA (2000) Abasic site recognition by two apurinic/ apyrimidinic endonuclease families in DNA base excision repair: the 3’ ends justify the means. Mutat Res 460: 211–229. 38. Heyduk T, Heyduk E (2002) Molecular beacons for detecting DNA binding proteins. Nat Biotechnol 20: 171–176. 39. Lea WL, Simeonov A (2011) Fluorescence Polarization Assays in Small Molecule Screening. Expert Op Drug Disc 6: 17–32. 40. Wyatt MD, Pittman DL (2006) Methylating agents and DNA repair responses: Methylated bases and sources of strand breaks. Chem Res Toxicol 19: 1580– 1594. 41. Chou T-C (2006) Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies. Pharmacological Reviews 58: 621–681. Large-Scale Screen for APE1 Inhibitors 42. Auparakkitanon S, Chapoomram S, Kuaha K, Chirachariyavej T, Wilairat P (2006) Targeting of hematin by the antimalarial pyronaridine. Antimicrob Agents Chemother 50: 2197–2200. 43. Naidu MD, Agarwal R, Pena LA, Cunha L, Mezei M, et al. (2011) Lucanthone and Its Derivative Hycanthone Inhibit Apurinic Endonuclease-1 (APE1) by Direct Protein Binding. PLoS ONE 6: e23679. 44. Shimozono N, Wada H, Biotech S (2004) Substituted Isoxazole Alkylamine Derivative and Agri- and Horticultural Fungicide. WO/2003/074501. 45. Rai G, Vyjayanti VN, Dorjsuren D, Simeonov A, Jadhav A, et al. (2012) Synthesis, Biological Evaluation, and Structure-Activity Relationships of a Novel Class of Apurinic/Apyrimidinic Endonuclease 1 Inhibitors. J Med Chem 55: 3101–3112. 46. Hong H, Neamati N, Winslow HE, Christensen JL, Orr A, et al. (1998) Identification of HIV-1 integrase inhibitors based on a four-point pharmaco- phore. Antivir Chem Chemother 9: 461–472. 47. Hwang JS, Lee SA, Hong SS, Han XH, Lee C, et al. (2010) Phenanthrenes from Dendrobium nobile and their inhibition of the LPS-induced production of nitric oxide in macrophage RAW 264.7 cells. Bioorg Med Chem Lett 20: 3785–3787. 48. Sun W, Cama LD, Birzin ET, Warrier S, Locco L, et al. (2006) 6H- Benzo[c]chromen-6-one derivatives as selective ERbeta agonists. Bioorg Med Chem Lett 16: 1468–1472. 49. Bowers EM, Yan G, Mukherjee C, Orry A, Wang L, et al. (2010) Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor. Chem Biol 17: 471–482. 50. Wang L, Gural A, Sun XJ, Zhao X, Perna F, et al. (2011) The leukemogenicity of AML1-ETO is dependent on site-specific lysine acetylation. Science 333: 765–769. 51. Walensky LD, Stewart ML, Cohen N, Institute D-FCR (2011) Small Molecules for the Modulation of MCL-1 and Methods for Modulating Cell Death, Cell Division, Cell Differentiation, and Methods of Treating Disorders. WPO, WO/ 2011/094708. 52. Xia G, Benmohamed R, Kim J, Arvanites AC, Morimoto RI, et al. (2011) Pyrimidine-2,4,6-trione Derivatives and Their Inhibition of Mutant SOD1- Dependent Protein Aggregation. Toward a Treatment for Amyotrophic Lateral Sclerosis. J Med Chem 54: 2409–2421. 53. Screpanti E, Santaguida S, Nguyen T, Silvestri R, Gussio R, et al. (2010) A Screen for Kinetochore-Microtubule Interaction Inhibitors Identifies Novel Antitubulin Compounds. PLoS ONE 5: e11603. 54. Rishton GM (1997) Reactive compounds and in vitro false positives in HTS. Drug Discovery Today 2: 382–384. PLOS ONE | www.plosone.org 12 October 2012 | Volume 7 | Issue 10 | e47974